BSE Live
Feb 20, 15:24Prev. Close
151.25
Open Price
150.05
Bid Price (Qty.)
150.70 (495)
Offer Price (Qty.)
151.30 (137)
NSE Live
Feb 20, 15:24Prev. Close
151.24
Open Price
151.24
Bid Price (Qty.)
150.56 (4)
Offer Price (Qty.)
150.96 (10)
| Balance Sheet of Suven Life Sciences (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 12.73 | 12.73 | 12.73 | 12.73 | 12.73 | |
| Total Share Capital | 12.73 | 12.73 | 12.73 | 12.73 | 12.73 | |
| Reserves and Surplus | 374.95 | 388.99 | 853.97 | 718.80 | 610.74 | |
| Total Reserves and Surplus | 374.95 | 388.99 | 853.97 | 718.80 | 610.74 | |
| Total Shareholders Funds | 387.67 | 401.72 | 866.70 | 731.53 | 623.47 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 1.08 | 1.78 | 2.22 | 25.93 | 41.64 | |
| Deferred Tax Liabilities [Net] | 5.87 | 20.49 | 23.24 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 3.40 | 0.76 | 1.05 | 1.34 | 1.48 | |
| Long Term Provisions | 1.72 | 1.49 | 3.69 | 2.84 | 2.39 | |
| Total Non-Current Liabilities | 12.07 | 24.51 | 30.20 | 30.11 | 45.52 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 30.57 | 30.49 | 24.16 | |
| Trade Payables | 5.78 | 7.09 | 56.82 | 37.94 | 35.60 | |
| Other Current Liabilities | 3.50 | 5.54 | 25.45 | 42.07 | 42.27 | |
| Short Term Provisions | 0.73 | 0.63 | 4.74 | 4.04 | 2.75 | |
| Total Current Liabilities | 10.01 | 13.26 | 117.58 | 114.53 | 104.79 | |
| Total Capital And Liabilities | 409.76 | 439.49 | 1,014.48 | 876.17 | 773.77 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 20.64 | 22.35 | 304.94 | 304.48 | 305.06 | |
| Intangible Assets | 4.05 | 0.00 | 2.78 | 1.25 | 0.30 | |
| Capital Work-In-Progress | 0.00 | 0.02 | 24.74 | 9.72 | 7.20 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 24.69 | 22.37 | 332.47 | 315.44 | 312.55 | |
| Non-Current Investments | 241.81 | 136.36 | 102.30 | 65.08 | 23.05 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 1.90 | 4.98 | |
| Long Term Loans And Advances | 91.25 | 0.00 | 0.04 | 0.03 | 0.02 | |
| Other Non-Current Assets | 0.00 | 0.00 | 17.01 | 6.54 | 6.15 | |
| Total Non-Current Assets | 357.76 | 158.73 | 451.81 | 388.98 | 346.74 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.05 | 222.93 | 278.73 | 300.89 | 0.05 | |
| Inventories | 0.00 | 0.00 | 139.47 | 92.51 | 83.46 | |
| Trade Receivables | 2.27 | 2.64 | 61.54 | 45.83 | 53.56 | |
| Cash And Cash Equivalents | 1.12 | 0.47 | 21.33 | 4.62 | 240.70 | |
| Short Term Loans And Advances | 42.01 | 47.50 | 0.10 | 0.08 | 0.12 | |
| OtherCurrentAssets | 6.55 | 7.21 | 61.50 | 43.25 | 49.13 | |
| Total Current Assets | 52.00 | 280.76 | 562.66 | 487.19 | 427.03 | |
| Total Assets | 409.76 | 439.49 | 1,014.48 | 876.17 | 773.77 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 47.57 | 0.00 | 11.77 | 8.04 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 20.73 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 200.12 | 185.70 | 93.51 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 13.57 | -- | 506.61 | 494.32 | 468.64 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 5.76 | 5.76 | 5.76 | 5.76 | 5.76 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 241.81 | 136.36 | 102.30 | 65.08 | 23.05 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | 300.89 | 0.05 | |
| Current Investments Unquoted Book Value | 0.05 | 222.93 | 278.73 | -- | -- |
30.01.2026
Suven Life Sci Consolidated December 2025 Net Sales at Rs 2.81 crore, up 74.46% Y-o-Y
30.01.2026
Suven Life Sci Standalone December 2025 Net Sales at Rs 2.81 crore, up 74.46% Y-o-Y
17.11.2025
Suven Life Sci Consolidated September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
12.11.2025
Suven Life Sci Standalone September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
30.01.2026
Suven Life Sci Consolidated December 2025 Net Sales at Rs 2.81 crore, up 74.46% Y-o-Y
30.01.2026
Suven Life Sci Standalone December 2025 Net Sales at Rs 2.81 crore, up 74.46% Y-o-Y
17.11.2025
Suven Life Sci Consolidated September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
12.11.2025
Suven Life Sci Standalone September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y